Using Allocation Exercises to Inform Clinical Trial Design

Posted by: Jonny Davis on 12/18/2018

Clinical trials are a significant portion of the cost to bring a new drug to market. Recent research published in Clinical Trials estimated the combined average total cost of conducting a single endocrinology clinical trial in each of Phases I, II, and III was US $30.5 million. With costs this high (and likely higher as time goes on), it’s natural to wonder if there are ways to optimize a clinical trial’s impact before committing to the substantial investment required. Fortunately, market research provides two opportunities to gauge the impact of a clinical trial through use of two designed experiment methodologies.

Read Full Post

Tags: Clinical trials | Pharmaceuticals | Endocrinology
Related Posts: Fall 2018